Caisse DE Depot ET Placement DU Quebec Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 304,819 shares of the company’s stock after acquiring an additional 106,246 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned 0.12% of HCA Healthcare worth $123,888,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Rockefeller Capital Management L.P. boosted its holdings in HCA Healthcare by 1.9% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 23,090 shares of the company’s stock valued at $9,380,000 after acquiring an additional 440 shares during the period. Martingale Asset Management L P increased its holdings in HCA Healthcare by 247.8% during the 3rd quarter. Martingale Asset Management L P now owns 59,758 shares of the company’s stock valued at $24,287,000 after purchasing an additional 42,577 shares during the period. Hantz Financial Services Inc. grew its position in shares of HCA Healthcare by 0.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 15,419 shares of the company’s stock worth $6,267,000 after buying an additional 139 shares during the last quarter. Vinva Investment Management Ltd raised its holdings in shares of HCA Healthcare by 15.9% during the third quarter. Vinva Investment Management Ltd now owns 9,457 shares of the company’s stock valued at $3,814,000 after acquiring an additional 1,298 shares in the last quarter. Finally, Financial Counselors Inc. raised its holdings in HCA Healthcare by 3.0% in the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company’s stock worth $630,000 after purchasing an additional 45 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Truist Financial raised their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Morgan Stanley began coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Finally, Barclays decreased their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

HCA Healthcare Trading Up 0.5 %

NYSE HCA opened at $327.24 on Friday. HCA Healthcare, Inc. has a 12 month low of $246.60 and a 12 month high of $417.14. The company’s 50-day moving average price is $371.88 and its 200-day moving average price is $358.35. The stock has a market cap of $82.89 billion, a PE ratio of 14.69, a PEG ratio of 1.25 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s payout ratio is currently 11.85%.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock worth $5,608,990 in the last three months. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.